Search Results - Tom Reuvekamp
- Showing 1 - 5 results of 5
-
1
Computational assessment of measurable residual disease in acute myeloid leukemia using mixture models by Tim R. Mocking, Angèle Kelder, Tom Reuvekamp, Lok Lam Ngai, Philip Rutten, Patrycja Gradowska, Arjan A. van de Loosdrecht, Jacqueline Cloos, Costa Bachas
Published in Communications Medicine (2024-12-01)Get full text
Article -
2
Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T‐cell therapy by Jort J. van derSchans, Paresh Vishwasrao, Renée Poels, Morgan Antti, Ziyu Wang, Marjolein Quik, Jennemiek vanArkel, Tom Reuvekamp, Niels W. C. J. van deDonk, Maria Themeli, Gert J. Ossenkoppele, Arjan A. van deLoosdrecht, Rebecca Richards, Tuna Mutis
Published in HemaSphere (2025-07-01)Get full text
Article -
3
P1536: SARS-COV-2 INFECTIONS IN PATIENTS WITH HAEMATOLOGIC MALIGNANCIES: EFFECT OF VACCINATION AND THE DEVELOPMENT OF HYBRID IMMUNITY by Sabine Haggenburg, Tom Reuvekamp, Quincy Hofsink, Cilia R. Pothast, Romy C. Dijkland, Kayleigh van Dijk, Annoek E.C. Broers, Jaap van Doesum, Rob S. van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J.E. Haverkate, Sandra Vogels-Nooijen, Inger S. Nijhof, Mirjam H.M. Heemskerk, Caroline E. Rutten, Abraham Goorhuis, Mette D. Hazenberg
Published in HemaSphere (2023-08-01)Get full text
Article -
4
Different features of acute myeloid leukemia stem cell quantification in intensively treated patients by Lok Lam Ngai, Tom Reuvekamp, Diana Hanekamp, Fleur Janssen, Laura Oudshoorn-van Marsbergen, Jannemieke Carbaat-Ham, Maaike A.M. Hofland, Mona M.H.E. Fayed, Angèle Kelder, Willemijn J. Scholten, Alexander N. Snel, Costa Bachas, Jesse M. Tettero, Dimitri A. Breems, Thomas Fischer, Bjørn T. Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Arjan A. van de Loosdrecht, Johan A. Maertens, Markus G. Manz, Thomas Pabst, Jakob R. Passweg, Kimmo Porkka, Peter J.M. Valk, Patrycja Gradowska, Bob Löwenberg, Gert J. Ossenkoppele, David C. de Leeuw, Jacqueline Cloos
Published in Haematologica (2025-04-01)Get full text
Article -
5
Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/refractory acute myeloid leukemia by Kathelijn Verdeyen, Tom Reuvekamp, Walter J.F.M. van der Velden, Bas J. Wouters, Peter A. von dem Borne, Anna van Rhenen, Birgit I. Lissenberg-Witte, Daniëlle van Lammeren, Geerte L. van Sluis, Eva de Jongh, Roel B. Fiets, Maarten F. Corsten, Arie C. van der Spek, Anke M. Gerrits, Esther R. van Bladel, Lidwine W. Tick, Okke de Weerdt, Bregje van Zaane, Marjan J. Cruijsen, Eduardus F.M. Posthuma, Catharina H.M.J. van Elssen, Saskia K. Klein, Arjan A. van de Loosdrecht, David C. de Leeuw
Published in Haematologica (2025-09-01)Get full text
Article
